BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3447533)

  • 1. Bacteriophage treatment of suppurative skin infections.
    Cisło M; Dabrowski M; Weber-Dabrowska B; Woytoń A
    Arch Immunol Ther Exp (Warsz); 1987; 35(2):175-83. PubMed ID: 3447533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results.
    Slopek S; Durlakowa I; Weber-Dabrowska B; Kucharewicz-Krukowska A; Dabrowski M; Bisikiewicz R
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):293-327. PubMed ID: 6651485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases.
    Slopek S; Durlakowa I; Weber-Dabrowska B; Dabrowski M; Kucharewicz-Krukowska A
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):317-35. PubMed ID: 6395825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases.
    Slopek S; Kucharewicz-Krukowska A; Weber-Dabrowska B; Dabrowski M
    Arch Immunol Ther Exp (Warsz); 1985; 33(2):219-40. PubMed ID: 2935115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children.
    Slopek S; Kucharewicz-Krukowska A; Weber-Dabrowska B; Dabrowski M
    Arch Immunol Ther Exp (Warsz); 1985; 33(2):241-59. PubMed ID: 2935116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.
    Slopek S; Weber-Dabrowska B; Dabrowski M; Kucharewicz-Krukowska A
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):569-83. PubMed ID: 3455647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results.
    Slopek S; Durlakowa I; Weber-Dabrowska B; Kucharewicz-Krukowska A; Dabrowski M; Bisikiewicz R
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):267-91. PubMed ID: 6651484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of suppurative-necrotic processes in the controlled germ-free environment with drug aerosols].
    Lutsevich EV; Lychkovskiĭ RM
    Khirurgiia (Mosk); 1990 Sep; (9):130-2. PubMed ID: 2273823
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenic effect of bacteriophage in patients subjected to phage therapy.
    Kucharewicz-Krukowska A; Slopek S
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):553-61. PubMed ID: 3455646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage therapy of bacterial infections: an update of our institute's experience.
    Weber-Dabrowska B; Mulczyk M; Górski A
    Arch Immunol Ther Exp (Warsz); 2000; 48(6):547-51. PubMed ID: 11197610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience using autovaccines in the treatment of chronic suppurative diseases].
    Trop IE
    Klin Med (Mosk); 1989 Feb; 67(2):112-4. PubMed ID: 2657208
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on bacteriophage penetration in patients subjected to phage therapy.
    Weber-Dabrowska B; Dabrowski M; Slopek S
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):563-8. PubMed ID: 3332066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of suppurative and septic diseases in children using ultrasonic cavitation].
    Ismaĭlov AA; Kuliev RA
    Vestn Khir Im I I Grek; 1985 Oct; 135(10):96-8. PubMed ID: 4090201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of noncontact, nonthermal, low-frequency ultrasound on bacterial counts in experimental and chronic wounds.
    Serena T; Lee SK; Lam K; Attar P; Meneses P; Ennis W
    Ostomy Wound Manage; 2009 Jan; 55(1):22-30. PubMed ID: 19174586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complex treatment of suppurative wounds using ultraviolet irradiation of the blood].
    Shaposhnikov IuG; Rudakov BIa; Berchenko GN; Berchenko VV; Kesian GA
    Khirurgiia (Mosk); 1988 Apr; (4):17-21. PubMed ID: 3398408
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections.
    Slopek S; Kucharewicz-Krukowska A; Weber-Dabrowska B; Dabrowski M
    Arch Immunol Ther Exp (Warsz); 1985; 33(2):261-73. PubMed ID: 2935117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New perspectives of the phage therapy].
    Eyer L; Pantůcek R; Růzicková V; Doskar J
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
    Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and animal experiment studies on the influencing of microbial dermatosses by peloids].
    Pöhler H; Schönborn C
    Z Physiother; 1971; 23(5):369-76. PubMed ID: 5168992
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacterial agents causing chronic suppurative otitis media.
    Obi CL; Enweani IB; Giwa JO
    East Afr Med J; 1995 Jun; 72(6):370-2. PubMed ID: 7498006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.